Cosmo Pharmaceuticals S.p.A Stock Swiss Exchange
Equities
IT0004167463
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CHF | - |
04-26 | Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 | CI |
04-25 | Cosmo Pharmaceuticals Names New CEO, Chairman | MT |
Sales 2023 | 96.72M 105M 95.48M 143M | Sales 2024 * | 262M 285M 259M 387M | Capitalization | 1.19B 1.29B 1.17B 1.75B |
---|---|---|---|---|---|
Net income 2023 | 1M 1.09M 987K 1.48M | Net income 2024 * | 111M 121M 110M 164M | EV / Sales 2023 | 8.6 x |
Net cash position 2023 | 48.44M 52.63M 47.82M 71.64M | Net cash position 2024 * | 110M 120M 109M 163M | EV / Sales 2024 * | 4.11 x |
P/E ratio 2023 |
771
x | P/E ratio 2024 * |
10.1
x | Employees | - |
Yield 2023 |
3.65% | Yield 2024 * |
2.84% | Free-Float | 44.49% |
Latest transcript on Cosmo Pharmaceuticals S.p.A
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 05-12-31 | |
Niall Donnelly
DFI | Director of Finance/CFO | 52 | 16-05-31 |
Chief Tech/Sci/R&D Officer | 54 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David W Maris
BRD | Director/Board Member | 57 | 21-05-27 |
Founder | 69 | 96-12-31 | |
Director/Board Member | 64 | 05-12-31 |
1st Jan change | Capi. | |
---|---|---|
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |